Telesis Bio Inc (NASDAQ:TBIO) shares are soaring in extended trading Wednesday after the company announced a partnership to ...

In recent trading, Telesis Bio Inc (TBIO) stock price has shown some volatility, fluctuating 36.18% over the last five trades and 16.33% over the past 30 trades. This represents a notable shift from ...

25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient and scalable ...

Shares of Telesis Bio were trading at double their closing price in the after-hours market following news the company entered a collaboration deal with Beckman Coulter Life Sciences.

In recent trading, Telesis Bio Inc (TBIO) stock price has shown some volatility, fluctuating 93.12% over the last five trades and -14.88% over the past 30 trades. This represents a notable shift from ...

The collaboration integrates Telesis Bio’s Gibson SOLA Enzymatic Synthesis technology with the new Biomek Echo One System from Beckman Coulter Life Sciences. It also delivers an open solution to the ...

Discover Telesis Bio Inc.'s groundbreaking patent for synthesizing specific DNA sequences. Learn how their innovative method enhances genetic engineering and biotechnology.

SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate ...

Telesis Bio and Beckman Coulter Life Sciences announced an new partnership on Thursday. The companies aim to revolutionize DNA and mRNA synthesis by creating efficient and scalable biofoundries.